Bengt Broman appointed new President of Skanditek subsidiary MYDATA automation AB

Report this content

The new President of MYDATA automation AB is Bengt Broman, currently President of Teracom AB. Bengt Broman was formerly President of LGP Allgon, where Skanditek was one of the principal owners.

“MYDATA is a successful Swedish innovation company with a strong global position within its market segment. It will be extremely stimulating leading MYDATA and its competent employees into the next phase of its development. My previous experience with Skanditek as principal owner is that the company adopts a long-term industrial approach, which I support,” says Bengt Broman. On his own initiative, Mårten Lundberg will be resigning as President of MYDATA automation and will remain in this position until Bengt Broman is able to take up the appointment. “Mårten Lundberg has very successfully developed MYDATA during his 18 years here. The company has grown from revenues of SEK 28 M in 1988 to SEK 643 M in 2005. I am very pleased that we were able to recruit Bengt Broman, who will now lead MYDATA into the next phase of development,” says Patrik Tigerschiöld, Chairman of MYDATA automation’s Board. MYDATA automation is a subsidiary of Skanditek, which owns 96 percent of the company. Stockholm, September 29, 2006 SKANDITEK INDUSTRIFÖRVALTNING AB (publ) For further information, contact: Bengt Broman, appointed new President, MYDATA automation mobile +46 70 570 10 30 Patrik Tigerschiöld, President, phone +46 8 614 00 20, mobile +46 70 777 71 90, e-mail patrik.tigerschiold@skanditek.se Skanditek is an industrial holding company owning stock in Swedish companies. The business concept is to be an active and long-term stockholder and to further the portfolio companies’ development by providing industrial and financial competence at board and management level. The portfolio comprises 11 companies within technology, biotechnology and services. The major holdings are in Bure Equity (10%), MYDATA automation (96%), PartnerTech (36%), Powerwave (1%) and Vitrolife (26%). Skanditek is listed on the Stockholm Exchange’s O-list.

Documents & Links